Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
This study presents a comprehensive overview of the efficacy of ixekizumab therapy for moderate-to-severe plaque psoriasis, based on two ixekizumab dosing regimens from pivotal phase III studies.
While phase III studies of crisaborole have shown it to be a safe treatment that improves symptoms of atopic dermatitis, does it really offer substantive therapeutic benefit over standard therapies?
Several biosimilars are now available for biologic therapies used to treat moderate-to-severe plaque psoriasis. This study compares long-term safety, efficacy, and drug survival data on these agents.
This study compared the efficacy and outcomes of two approved treatments for actinic keratosis on the face and scalp: ingenol mebutate and diclofenac sodium. Is one superior to the other?
Condylomata acuminata of HIV-positive men may harbour focal areas of dysplasia: relevant implications for the management of human papillomavirus-induced disease in high-risk patients.
Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ��� 50 years.
The new Cutaneous Lymphoma International Prognostic index (CLIPi) for early mycosis fungoides failed to identify prognostic groups in a cohort of Spanish patients.
An autoimmune bullous dermatosis with clinical, histopathological and immunological features of bullous pemphigoid and epidermolysis bullosa acquisita in an adult.
Preoperative prediction of histopathological outcome in basal cell carcinoma: flat surface and multiple small erosions predict superficial basal cell carcinoma in lighter skin types.
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(��) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(��) lamp.
CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature.
